Satlin et al. 199237
|
open clinical trial-evening bright light |
10 hospital patients |
1500–2000 |
2 hours 19:00–21:00 |
sleep wake patterns (ID variability) improved, nighttime activity decreased, improved ratings of sleep-wakefulness |
Colenda et al. 199747
|
single subject, 28 days total |
5 community dwelling |
2000 |
2 hours 07:00–09:30 |
no significant changes from baseline in acrophase, mesor or amplitude in 4 of 5 subjects |
Van Someren et al. 199736
|
open trial |
22 inpatients |
varied mean = 1130 |
all day |
increased interdaily stability |
Okumoto et al. 199850
|
open trial |
1 nursing home resident |
4000 |
2 hours 09:30–11:30 |
consolidated sleep episodes at night |
Koyama et al. 199949
|
open trial |
6 nursing home residents |
4000 |
late morning |
percent sleep increased and percent wakefulness in daytime increased in 3 of the 6 subjects; in the other 3, sleep onset was advanced |
Lyketosos et al. 199938
|
randomized controlled crossover trial |
15 inpatients in a chronic care facility |
10,000 |
1 hour morning |
significant improvement in nocturnal sleep amount after 4 weeks |
Yamadera et al. 200040
|
1-week adaptation, 1-week pre-treatment, 4-week treatment |
27 hospital patients |
3000 |
09:00–11:00 |
significant improvement in circadian rhythms disturbances and in cognition |
Ancoli-Israel et al. 200251
|
randomized controlled trial; evening bright light, morning bright light, evening dim red light or daytime sleep restriction |
77 nursing home residents |
2500 |
17:30–19:30 or 09:30–11:30 |
no improvements in nighttime sleep or daytime alertness in any group; morning bright light delayed the peak of the activity, increased mean activity and improved activity rhythmicity |
Fetveit et al. 200334
|
open non-randomized |
11 nursing home residents |
6000–8000 |
2 hours within 08:00–11:00 |
sleep efficiency increased, total wake time reduced, sleep onset latency reduced |
Ancoli-Israel et al. 200339
|
randomized controlled trial; morning bright light, morning dim red light or evening bright light |
92 nursing home residents |
2500 |
2 hours 09:30–11:30 or 2 hours 17:30–19:30 |
more consolidated sleep at night and improve rhythm stability |
Fontana Gasio et al. 200346
|
randomized controlled trial |
13 nursing home residents |
mean = 200 |
all day dawn-to-dusk simulator |
earlier onset sleep time and longer sleep duration |
Figueiro et al. 200345
|
placebo controlled crossover design; 2 weeks of 640-nm (red) light and 2 weeks of 470-nm (blue) light |
4 nursing home residents |
30 |
2 hours 18:00–20:00 |
470-nm light delayed decline in tympanic temperature and increased observations of nighttime sleep efficiency |
Fetveit and Bjortvan 200548
|
pre-treatment, treatment and post treatment |
11 nursing home residents |
6000–8000 |
2 hours within 08:00–11:00 |
average and total daytime nap duration were reduced |
Dowling et al. 200541
|
randomized bright light to usual light and randomized morning bright light to afternoon bright light |
46 nursing home residents |
>2500 mean = 7500 |
1 hour between 09:30–10:30 |
no significant changes in sleep efficiency, sleep time, wake time, or number of awakenings between experimental group and control group; improved rhythm stability in those with most impaired rest- activity rhythms |
Alessi et al. 200535
|
randomized controlled trial |
118 nursing home residents |
sunlight >10,000 |
at least 30 minutes |
significant decrease daytime sleep and decrease in duration of nighttime awakenings; increased participation in social activities |
Figueiro and Rea 200544
|
placebo controlled crossover design; 10 days of 640-nm (red) light and 10 days of 470-nm (blue) light crossover |
4 nursing home residents |
30 |
2 hours 17:00–19:00 |
increased observations of nighttime sleep efficiency after 470-nm light exposure compared to 640-nm light |
Sloane et al. 200742
|
intervention trial; morning bright light, evening bright light and all day bright light |
66 inpatient and residential care |
2500 |
2 hours 07:00–11:00 or 2 hours 16:00–20:00 or 07:00–20:00 |
nighttime sleep increased in the morning and all day light groups, morning light phase advance and evening light phase delay |
Riemersma-van der Lek et al. 200843
|
long term (3.5 yrs) randomized double blind placebo- controlled whole-day bright or dim light and evening melatonin or placebo |
189 care facility residents |
Bright: 1000 Dim: 300 |
09:00–18:00 |
bright light alone attenuated cognitive deterioration by a relative 5%, ameliorated depressive symptoms by a relative 19%, and attenuated the increase in functional limitations over time by relative 53% |